跳至主要内容
临床试验/NCT00599820
NCT00599820终止3 期

OCT, Visual Outcome and Angiographic Analysis of Choroidal Neovascularization in Six Eyes With Angioid Streaks Treated With a Single Intravitreal Injection of Bevacizumab

Asociación para Evitar la Ceguera en México1 个研究点 分布在 1 个国家开始时间: 2005年11月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
终止
发起方
试验地点
1
主要终点
Optical Coherence Tomography

研究概览

简要总结

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks

详细描述

A consecutive case series of patients with angioid streaks that developed subfoveal choroidal neovascularization were treated with a primary 2.5 mg injection of Bevacizumab (Avastin) intravitreally. All patients were evaluated with BCVA at 1, 2 , 4 and 12 weeks and OCT and fluoresceine angiography at month 1 and 3. (Patients will be follow 6 months)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Angioid Streaks
  • Choroidal neovascularization associated
  • Untreated patients or patients treated once with PDT

排除标准

  • Ocular surgery excepting uncomplicated phacoemulsification
  • Glaucoma or any other ocular pathology

结局指标

主要结局

Optical Coherence Tomography

BCVA

Fluoresceine Angiography

次要结局

未报告次要终点

研究者

发起方
Asociación para Evitar la Ceguera en México
申办方类型
Other

研究点 (1)

Loading locations...

相似试验